ArticlePharmaceutics2021

External Model Performance Evaluation of Twelve Infliximab Population Pharmacokinetic Models in Patients with Inflammatory Bowel Disease.

Christina Schräpel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.